Turtle Cameron
Reporting owner on Forms 3, 4 and 5, CIK 1758363.
Turtle Cameron reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Spyre Therapeutics, Inc. CIK 1636282 | director, officer (Chief Executive Officer) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -600 | $89.14 | 551,940 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -2,683 | $90.1 | 549,257 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -2,638 | $91.49 | 546,619 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -3,989 | $92.31 | 542,630 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -4,990 | $93.37 | 537,640 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -100 | $93.91 | 537,540 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001636282-26-000118 | Spyre Therapeutics, Inc. | 2026-10-02 |